alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
III 

112TH CONGRESS 

2D SESSION S. RES. 286 

Recognizing May 16, 2012, as Hereditary Angioedema Awareness Day and 

expressing the sense of the Senate that more research and treatments 

are needed for Hereditary Angioedema. 

IN THE SENATE OF THE UNITED STATES 

OCTOBER 5, 2011 

Mr. INOUYE (for himself and Mr. CHAMBLISS) submitted the following 

resolution; which was referred to the Committee on the Judiciary 

JANUARY 31, 2012 

Committee discharged; considered, amended, and agreed to 

RESOLUTION 

Recognizing May 16, 2012, as Hereditary Angioedema 

Awareness Day and expressing the sense of the Senate 

that more research and treatments are needed for Hereditary Angioedema. 

Whereas Hereditary Angioedema (HAE) is a rare and potentially life-threatening genetic disease, affecting between 1 

in 10,000 and 1 in 50,000 people, leading to patients 

being undiagnosed or misdiagnosed for many years; 

Whereas HAE is characterized by symptoms including episodes of edema or swelling in various body parts including the hands, feet, gastrointestinal tract, face, and airway; 


smartinez on DSK6TPTVN1PROD with BILLS
2 

SRES 286 ATS 

Whereas patients often experience swelling in the intestinal 

wall, causing bouts of excruciating abdominal pain, nausea, and vomiting, and swelling of the airway, which can 

lead to death by asphyxiation; 

Whereas a defect in the gene that controls the C1-inhibitor 

blood protein causes production of either inadequate or 

non-functioning C1-inhibitor protein, leading to an inability to regulate complex biochemical interactions of bloodbased systems involved in disease fighting, inflammatory 

response, and coagulation; 

Whereas HAE is an autosomal dominant disease, and 50 percent of patients with the disease inherited the defective 

gene from a parent, while the other 50 percent developed 

a spontaneous mutation of the C1-inhibitor gene at conception; 

Whereas HAE patients often experience their first HAE attack during childhood or adolescence, and continue to 

suffer from subsequent attacks for the duration of their 

lives; 

Whereas HAE attacks can be triggered by infections, minor 

injuries or dental procedures, emotional or mental stress, 

and certain hormonal or blood medications; 

Whereas the onset or duration of an HAE attack can negatively affect a person’s physical, emotional, economic, 

educational, and social well-being due to activity limitations; 

Whereas the annual cost for treatment per patient can exceed 

$500,000, causing a substantial economic burden; 

Whereas there is a significant need for increased and normalized medical professional education regarding HAE; and 


smartinez on DSK6TPTVN1PROD with BILLS
3 

SRES 286 ATS 

Whereas there is also a significant need for further research 

on HAE to improve diagnosis and treatment options for 

patients; Now, therefore, be it 

1 Resolved, That— 

2 (1) the Senate— 

3 (A) recognizes and celebrates May 16, 

4 2012, as Hereditary Angioedema Awareness 

5 Day; and 

6 (B) supports increased awareness of He7 reditary Angioedema (HAE) by physicians and 

8 the public. 

Æ 


smartinez on DSK6TPTVN1PROD with BILLS
**Exhibit 31.2**

 

CERTIFICATION PURSUANT TOSARBANES-OXLEY ACT OF 2002

 

I, Allan Rowley, certify that:

 

1. I have reviewed this annual report on Form 10-Kof MGT Capital Investments Inc;

 

2.Based on my knowledge, this report does not contain any untrue statement of amaterial fact or omit to state a material fact necessary to make the statementsmade, in light of the circumstances under which such statements were made, notmisleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financialinformation included in this report, fairly present in all material respectsthe financial condition, results of operations and cash flows of the registrantas of, and for, the periods presented in this report;

 

4. Theregistrant’s other certifying officer and I are responsible for establishingand maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have:

 

(a) Designedsuch disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that materialinformation relating to the registrant, including its consolidatedsubsidiaries, is made known to us by others within those entities, particularlyduring the period in which this report is being prepared;

 

(b) Evaluatedthe effectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of the disclosurecontrols and procedures, as of the end of the period covered by this reportbased on such evaluation; and

 

(c) Disclosedin this report any change in the registrant’s internal control over financialreporting that occurred during the registrant’s most recent fiscal quarter (theregistrant’s fourth fiscal quarter in the case of an annual report) that hasmaterially affected, or is reasonably likely to materially affect, theregistrant’s internal control over financial reporting; and

 

5. Theregistrant’s other certifying officer and I have disclosed, based on our mostrecent evaluation of internal control over financial reporting, to theregistrant’s auditors and the audit committee of the registrant’s board ofdirectors (or persons performing the equivalent functions):

 

(a) Allsignificant deficiencies and material weaknesses in the design or operation ofinternal control over financial reporting which are reasonably likely toadversely affect the registrant’s ability to record, process, summarize and reportfinancial information; and

 

(b) Any fraud, whether or not material, thatinvolves management or other employees who have a significant role in theregistrant’s internal control over financial reporting.

 
|   | By:                     | /s/ ALLAN ROWLEY |
|--------|-------------------------|------------------|
|   | Allan Rowley            |
|   | Chief Financial Officer |

March 17, 2008

 

E-3

----
**Exhibit 32.2**

** **

**Written StatementPursuant To18 U.S.C. Section 1350**

** **

The undersigned, John A. Elwood, the ChiefFinancial Officer of Meade Instruments Corp. (the “Company”), pursuant to 18U.S.C. § 1350, hereby certifies that:

 

(i)   theForm 10-Q for the quarterly period ended November 30, 2008 of theCompany, as amended by Amendment No. 1, (the “Report”) fully complies with therequirements of Sections 13(a) and 15(d) of the Securities ExchangeAct of 1934; and

 

(ii)  theinformation contained in the Report fairly presents, in all material respects,the financial condition and results of operations of the Company.

 

Date: March 27, 2009

 
| By:      | /s/  JOHN A. ELWOOD                                        |     |
|----------|------------------------------------------------------------|----------|
| * * | *Vice  President—Finance and Chief Financial Officer* | * * |

 

----
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Global Change and Photosynthesis Research: Urbana, IL
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                People

                    Staff Listing
                                    CareersSearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Midwest Area Urbana, Illinois Global Change and Photosynthesis Research People & Locations





- Find a person
- Find a location
- ARS Organizational Chart
- People
- Contact Information
- ARS News Articles
- Research Projects
- Publications

Elizabeth A Ainsworth

(Lisa)
                     

                     Research Molecular Biologist
                     


                     ARS News Articles
                        item
                                             Monitoring Ground-Level Ozone from Spaceitem
                                             Some Crops Tolerate Ozone Pollution Better Than Others, Study Findsitem
                                             New Crop-Yield Study Casts Doubt on a Climate-Change Predictionitem
                                             ARS Molecular Biologist Elizabeth Ainsworth Receives National Academy of Sciences Prize in Food and Agriculture Sciencesitem
                                             Scientists Find Ozone Levels Already Affecting Soybean Yieldsitem
                                             USDA's Agricultural Research Service Honors Scientists of the Yearitem
                                             Breeding Ozone-Tolerant Crops


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov
**EXHIBIT31.2**

**CERTIFICATIONPURSUANT TO**

**SECTION302 OF THE SARBANES-OXLEY ACT OF 2002**

I, R. Scott Ervin,acting as the interim Chief Financial Officer, certify that:

1. I have reviewedthis quarterly report of Force Protection, Inc.;

2. Based on myknowledge, this report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, inlight of the circumstances under which such statements were made, notmisleading with respect to the period covered by this report;

3. Based on myknowledge, the financial statements, and other financial information includedin this report, fairly present in all material respects the financialcondition, results of operations and cash flows of the small business issuer asof, and for, the periods presented in this report;

4. The smallbusiness issuer’s other certifying officer(s) and I are responsible forestablishing and maintaining disclosure controls and procedures (as defined inExchange Act Rules 13a-15(e) and 15d-15(e)) for the small business issuer andhave:

(a) Designed such disclosure controls and procedures,or caused such disclosure controls and procedures to be designed under oursupervision, to ensure that material information relating to the small businessissuer, including its consolidated subsidiaries, is made known to us by otherswithin those entities, particularly during the period in which this report isbeing prepared;

(b) Evaluated the effectiveness of the small businessissuer’s disclosure controls and procedures and presented in this report ourconclusions about the effectiveness of the disclosure controls and procedures,as of the end of the period covered by this report based on such evaluation;and

(c) Disclosed in this report any change in the smallbusiness issuer’s internal control over financial reporting that occurredduring the small business issuer’s most recent fiscal quarter (the smallbusiness issuer’s fourth fiscal quarter in the case of an annual report) thathas materially affected, or is reasonably likely to materially affect, thesmall business issuer’s internal control over financial reporting; and

5. The smallbusiness issuer’s other certifying officer(s) and I have disclosed, based onour most recent evaluation of internal control over financial reporting, to thesmall business issuer’s auditors and the audit committee of the small businessissuer’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and materialweaknesses in the design or operation of internal control over financialreporting which are reasonably likely to adversely affect the small businessissuer’s ability to record, process, summarize and report financialinformation; and

(b) Any fraud, whether or not material, that involvesmanagement or other employees who have a significant role in the small businessissuer’s internal control over financial reporting.

 
| Date:  August 14, 2006 |
|-----------------------------|
|                        | /s/ R. Scott  Ervin |   |
|                        | R. Scott Ervin |
|                        | Acting Chief Financial  Officer |

 

----
# Official Journal C 1/2020

| | ISSN 1977-091X |
| --- | --- |
| Official Journal
  of the European Union | C 1 |
| | |
| English edition | Information and Notices | Volume 633 January 2020 |

ISSN 1977-091X

Official Journal

of the European Union

C 1

English edition

Information and Notices

Volume 633 January 2020

---

| Contents | page |
| --- | --- |
| | IV   Notices |
| | NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
| | European Commission |
| 2020/C 1/01 | Euro exchange rates — 30 December 2019 | 1 |
| 2020/C 1/02 | Euro exchange rates — 31 December 2019 | 2 |
| 2020/C 1/03 | Euro exchange rates — 2 January 2020 | 3 |

Contents

page

IV   Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

2020/C 1/01

Euro exchange rates — 30 December 2019

1

2020/C 1/02

Euro exchange rates — 31 December 2019

2

2020/C 1/03

Euro exchange rates — 2 January 2020

3

---

| | V   Announcements |
| --- | --- |
| | PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY |
| | European Commission |
| 2020/C 1/04 | Prior notification of a concentration (Case M.9633 — Astorg/Nordic Capital/Novo/ERT) Candidate case for simplified procedure (
  1
  ) | 4 |

V   Announcements

PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY

European Commission

2020/C 1/04

Prior notification of a concentration (Case M.9633 — Astorg/Nordic Capital/Novo/ERT) Candidate case for simplified procedure (
  1
  )

1

4

---

| | |
| --- | --- |
| | (1)   Text with EEA relevance. |

---

(1)   Text with EEA relevance.

1

| EN | |
| --- | --- |

EN
##### 



Exhibit 13.1 Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a)
and (b) of Section 1350, Chapter 63 of Title 18, United States Code), each of
the undersigned officers of De Rigo S.p.A. (the Company), does hereby
certify, to such officers knowledge, that: The Annual Report on Form 20-F for the fiscal year ended December 31, 2003
of the Company fully complies with the requirements of section 13(a) or 15(d)
of the Securities Exchange Act of 1934 and information contained in the Form
20-F fairly presents, in all material respects, the financial condition and
results of operations of the Company. Dated: June 30, 2004
    
    /s/ Ennio De RigoName: Ennio De RigoTitle: Chief Executive OfficerDated: June 30, 2004
    
    /s/ Maurizio DessolisName: Maurizio DessolisTitle: Chief Financial Officer
 A signed original of this written statement required by Section 906 has been
provided to De Rigo S.p.A. and will be retained by De Rigo S.p.A. and furnished
to the Securities and Exchange Commission or its staff upon request.
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT
No. 95-7542
BEVERLY RICARDO MANGUM, Plaintiff - Appellant, versus L. W. HUFFMAN; J. B. TAYLOR; D. C. STEWART; A. L. CRAWFORD; SERGEANT BERRY; H. BOOTH-BROWN; C/O CARTER, JR.; G. DEDRICK; LYNN COX; G. P. HACTON; LIEUTENANT JONES; M. W. MURPHY; P. N. KNIGHT, Captain; S. W. HOLLOR; T. S. MILLER; F. S. ROBINSON; T. STEWART; C/O PROCTOR; L. SHEFFER; ASSISTANT WARDEN JARVIS; S. FARRISH; C/O KEY; C/O HAROLD; SERGEANT HENRY; L. PAINTER; CAPTAIN SPITLER; R.R. HOLLOWAY; C/O EUTSLER; P. JOHNSON; C/O WALTERS; R. DAWSON; J. LEE; L. M. SAUNDERS; P. MASSIE; C/O SPEARS; R. L. FRADY; J. H. LYLE, Lieutenant; C/O FLETCHER; C/O GARRETT; SERGEANT SLIVER; SERGEANT TAYLOR; D. SWISHER; R. BOYER, Defendants - Appellees, and SERGEANT HENNY; D. N. FOLEY; C/O ALLEN; SERGEANT HARRIS; K. BAILEY; UNKNOWN MEMBERS OF THE APPEALS UNIT, Defendants.
Appeal from the United States District Court for the Western District of Virginia, at Roanoke. Samuel G. Wilson, District Judge. (CA-94-403-R)2 Submitted: April 15, 1996 Decided: April 23, 1996 Before ERVIN and MOTZ, Circuit Judges, and CHAPMAN, Senior Circuit Judge. Affirmed by unpublished per curiam opinion. Beverly Ricardo Mangum, Appellant Pro Se. Pamela Anne Sargent, Assistant Attorney General, Richmond, Virginia, for Appellees. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).

PER CURIAM: Appellant appeals from the district court's orders denying relief on his 42 U.S.C. § 1983 (1988) complaint and Fed. R. Civ. P. 59(e) motion to alter or amend the judgment. We have reviewed therecord and the district court's opinion and find no abuse of discretion and no reversible error. Accordingly, we affirm on the reasoning of the district court. Mangum v. Huffman , No. CA-94-403-R (W.D. Va. Sept . 5 & 15, 1995). We dispense with oral argument because the facts and legal contentions are adequately presented inthe materials before the court and argument would not aid the decisional process.

AFFIRMED
<TABLE> <S> <C>


<ARTICLE>                     5
<MULTIPLIER>                  1
<CURRENCY>                    U.S. DOLLARS                 
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                             SEP-30-1997          
<PERIOD-START>                                OCT-01-1996
<PERIOD-END>                                  JUN-30-1997
<EXCHANGE-RATE>                                         1
<CASH>                                             33,362 
<SECURITIES>                                            0 
<RECEIVABLES>                                      16,076 
<ALLOWANCES>                                            0 
<INVENTORY>                                        15,647 
<CURRENT-ASSETS>                                   65,085 
<PP&E>                                              4,748 
<DEPRECIATION>                                          0 
<TOTAL-ASSETS>                                    272,370 
<CURRENT-LIABILITIES>                             285,828 
<BONDS>                                                 0 
<PREFERRED-MANDATORY>                                   0 
<PREFERRED>                                             0 
<COMMON>                                            4,980 
<OTHER-SE>                                        412,562 
<TOTAL-LIABILITY-AND-EQUITY>                      272,370 
<SALES>                                            32,170 
<TOTAL-REVENUES>                                   32,170 
<CGS>                                              21,168 
<TOTAL-COSTS>                                      21,168 
<OTHER-EXPENSES>                                  377,466 
<LOSS-PROVISION>                                        0 
<INTEREST-EXPENSE>                                      0 
<INCOME-PRETAX>                                  (366,466)
<INCOME-TAX>                                            0 
<INCOME-CONTINUING>                              (366,464)
<DISCONTINUED>                                          0 
<EXTRAORDINARY>                                         0 
<CHANGES>                                               0 
<NET-INCOME>                                     (366,093)
<EPS-PRIMARY>                                        (.07)
<EPS-DILUTED>                                        (.07)
                                               

</TABLE>
TH THE UMITED STATES DISUMICT Court Fy L 5
FOR THE MORTHELA DISTRICT OF TLIVOTS ocr OB roy

- EASTERN DIVISION , Moras .
fe ° ERK, LS nor
UNTIED STATES OF AUEKECA ) ISTE
Plaati€é )
) MM. 03 CRI
uv )
MATHEW HALE )  Dadge Jaces 7. me
Debeadact ) Csilbing by aesigarhen

MNottce OF FILING
By U.S. Nail to:

Jucbye Janus To Maod, mM. David Ufeisnraa

7
shiek Coat Asst. Ws. Atarn
yarted Sates istic OM. bee oy ble

Wethera istrict of trang,
5400 Fedual Plaza Aierzo, IL CHOY

taotmond IM e320

DIEASE TAKE MOTECE Hed on his as cy of October

2A0Y +e undersigned auailed ta th Chih of the Wishiet Court for the
Notthera beshict o€ thasis +t Kieazo. Tihasis, th atHahd AiGjd ait of
Sloan Grermald far filiag, 4 copy of which is kueby served apeor you.

Vaspecthally setheritted,
tli, dle
Atofthin F- Yale pre se 4 /s177Vey :
Metrepelidan Correctional Garter
Tl Uist Yan Shana Street
Chiergo, Tk €060S



TW THE UWLTE? STATES DISTRICT Count.
Com tHe Moxtheew orsneact of turers Eh, py

EASTERN DIYISLON ocr 0m
MICHAEL vy Doge,
rey a * BOSBIN
UALTTEY STATES OF AMEKICA >) LERK, U.S. DISTRICT cog
Piatt, )
> MM. 03 CK Il
Y )
MATHEW, HALE, )  Tadge Jaens T. Mood,
C 47 ty
Uebiadaat ) Csitfs “9 ia clesinagfion)

Atbduit ot Ghaa bree ld

Mow CUMes AVATIEW HALE, prose ofteriag th atbrched

atbidwit Cs) ia farther support ot Ais poadeg ayehjien tory aw trial
bled oq dunt 2Y, 2004 pursaaat fo Rah 33&) ad (XZ) 2€ Le fedees|

Pals ot Crimean Vraectare:
Resnettally suluitted,

Eis thle

Aah F. Hale

7
#### The People of the State of New York, Respondent, v Samuel McNear, Appellant.

[948 NYS2d 841]

Motion for reargument granted, and upon reargument, the coram nobis motion is denied. Present — Scudder, P.J., Fahey, Carni, Lindley and Sconiers, JJ.